<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Infants born from mothers with <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> (aPL) -positive <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> were prospectively evaluated for anticardiolipin and anti-beta2 <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I antibodies (group 1) and for growth and neurological development </plain></SENT>
<SENT sid="1" pm="."><plain>The results were compared with those obtained from two age-matched control groups (group 2 and 3) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> infants were negative for anticardiolipin at 12 months of life, whereas 14 (63.6%), eight (33.3%), and 10 (55.5%) of infants from group 1, 2, and 3, respectively, were positive for anti-beta2 <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I </plain></SENT>
<SENT sid="3" pm="."><plain>At follow-up, <z:hpo ids='HP_0000001'>all</z:hpo> infants had <z:mpath ids='MPATH_458'>normal</z:mpath> growth and neurological development </plain></SENT>
<SENT sid="4" pm="."><plain>No thrombotic complication was observed </plain></SENT>
<SENT sid="5" pm="."><plain>The negativity of anticardiolipin in <z:hpo ids='HP_0000001'>all</z:hpo> infants at 12 months suggests that anticardiolipin detection is the best assay to evaluate the disappearance of maternal aPL and to estimate the potential risk of <z:mp ids='MP_0005048'>thrombosis</z:mp> associated with these antibodies </plain></SENT>
<SENT sid="6" pm="."><plain>The high rate of anti-beta2 <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I positivity in <z:hpo ids='HP_0000001'>all</z:hpo> three groups of infants may indicate that the synthesis of this antibody is stimulated by aspecific factors </plain></SENT>
</text></document>